Providers compared

Curex, Food Allergy Institute, Latitude, Allergychoices and UAS

Five food allergy options: treatment method, location, published price status, eligibility, evidence and fit — including what the alternatives offer beyond remote drops.

Short answer

Curex offers telemedicine-supervised food allergy drops with home delivery. Food Allergy Institute offers TIP food dosing with required clinic visits; Latitude offers clinic OIT, food challenges and Xolair. Allergychoices supplies custom food drops through participating prescribers, while UAS offers partner-clinic food drops with an observed first dose for each bottle. They differ in method, supervision and eligibility, not just price. Curex food-plan rates, checked 2026-10-09: Curex Food Insurance Plan: $199/month or $1,990/year, plus specialist copay; Curex Combo Insurance Plan: $259/month or $2,590/year, plus specialist copay; Curex Food Self Pay Plan: $249/month or $2,490/year; Curex Combo Self Pay Plan: $299/month or $2,990/year. Annual figures are plan prices, not all-in totals. Treatment fees are out of pocket; testing and consultations are insurance-dependent. See /learn/curex-pricing and confirm eligibility, additional charges and a personalized written quote

Medically reviewed by Dr. Neeta Ogden, MD, FACAAI · Last reviewed October 2026

Side by side

Five food allergy providers, side by side

Provider pages checked October 5, 2026. Curex pricing was checked separately against its onboarding tool on 2026-10-09; clinical and competitor review dates are unchanged. See Curex plan pricing. Prices, eligibility and schedules can change; request a current written program quote.

Curex

Telemedicine food SLITThat’s us

Food treatment method: Prescription sublingual immunotherapy (SLIT): daily food allergen drops under the tongue, compounded to the prescription. Not food allergy shots.
Delivery and location: Telemedicine in all 50 U.S. states; drops shipped home. A supervised oral food challenge requires an appropriate in-person clinical setting, not a home test.
Pricing and publication status: Curex food-plan rates, checked 2026-10-09: Curex Food Insurance Plan: $199/month or $1,990/year, plus specialist copay; Curex Combo Insurance Plan: $259/month or $2,590/year, plus specialist copay; Curex Food Self Pay Plan: $249/month or $2,490/year; Curex Combo Self Pay Plan: $299/month or $2,990/year. Annual figures are plan prices, not all-in totals. Treatment fees are out of pocket; testing and consultations are insurance-dependent. See /learn/curex-pricing and confirm eligibility, additional charges and a personalized written quote
Treatment commitment: Daily dosing over a multi-year course; ask the prescribing clinician for the food-specific plan and follow-up schedule.
Patient eligibility: Adults and children from age 2 with confirmed IgE-mediated food allergy, subject to clinical review. Not a treatment for food intolerance.
Outcomes and evidence boundaries: No published Curex-specific food outcome study identified in this review. Its environmental-allergy study is not food evidence. Published peanut-SLIT trials support the method in studied populations, not a Curex success rate or every food formulation.
Best fit: Eligible patients who need remote clinical care and home delivery rather than routine travel to a treating clinic.
What this option offers: Remote access and home delivery; compare this convenience with the in-person challenges and supervision available through clinic-based alternatives.

Sources checked October 5, 2026: Curex food program · Curex plan pricing, checked 2026-10-09

Food Allergy Institute

TIP food dosing

Food treatment method: Tolerance Induction Program (TIP): personalized real-food dosing, beginning with similar food proteins before direct allergen exposure. FAI lists SLIT as an additional service; do not assume every patient receives it.
Delivery and location: Required in-person care at California or New Jersey clinics, or the Dallas affiliate, plus home dosing. The homepage describes 4–6 visits/year; the cost page describes 10–12 annual in-office visits. Confirm the schedule for your plan.
Pricing and publication status: $979/month subscription for ages 18 months–25 years; $1,079/month for ages 26–50 on its cost page. That page also says SLIT, food-dose replacements and additional testing can be separate: request a written quote and exclusions.
Treatment commitment: Homepage describes a 2.5–4-year program; individual plans vary.
Patient eligibility: Homepage describes qualifying patients ages 15 months–50, including severe, multiple-food and complex cases. The subscription price table begins at 18 months: confirm eligibility and pricing for younger children.
Outcomes and evidence boundaries: Homepage claims “99% success rate after completing TIP” and “<1% reaction rate.” These are provider-published claims, not a head-to-head comparison; the completion denominator and reaction definition matter.
Best fit: Patients seeking a structured multi-food program who can sustain its required visits and home food dosing.
What this option offers: Dedicated in-person food challenges, complex-case evaluation and a personalized multi-food pathway that a remote drops service does not provide onsite.

Sources checked October 5, 2026: FAI program, eligibility and claims · FAI treatment cost and exclusions

Latitude Food Allergy Care

Clinic OIT and Xolair

Food treatment method: Oral immunotherapy (OIT) with measured food doses; oral food challenges and Xolair are also offered. Its checked FAQ does not describe routine combined food SLIT/OIT.
Delivery and location: Clinics in Northern and Southern California and New York. Updosing generally every two weeks during active OIT, with daily home doses and clinical monitoring.
Pricing and publication status: No dollar amount published in the checked FAQ. Diagnostic and office visits are typically insurance-covered subject to the plan; a one-time OIT program fee is not billable to insurance. Program quote required; no patient-reported estimate used here.
Treatment commitment: FAQ describes 6–12 months to maintenance, averaging 8.4 months, followed by long-term daily maintenance dosing.
Patient eligibility: Adults and children as young as 9 months for OIT after diagnostic, reaction-history and medical review; single or multiple foods.
Outcomes and evidence boundaries: Checked FAQ reports 92% of OIT patients reaching maintenance and 97% under age 4. These are Latitude-reported maintenance figures, not a cure rate, not identical to a food-challenge endpoint, and not directly comparable with TIP completers or peanut-SLIT trials.
Best fit: Patients within reach of its clinics who want supervised OIT or an assessment of Xolair and can attend updosing visits.
What this option offers: Onsite oral food challenges and OIT updosing, with Xolair as another treatment option and in-network visit billing where the insurance plan qualifies.

Sources checked October 5, 2026: Latitude treatment, outcomes, eligibility and insurance FAQ

Allergychoices

Pharmacy and provider network

Food treatment method: Custom food SLIT using the La Crosse Method protocol, prescribed through participating clinicians. Its food page recommends three daily doses; follow the individual prescription.
Delivery and location: A compounding pharmacy and provider-support network, not one treating clinic. Its provider-finder helps locate a clinician; confirm that the specific practice offers food SLIT and its visit or remote-care arrangements.
Pricing and publication status: Food allergy prescriptions begin at $173 for 90 days on the published cost page, paid out of pocket. This is a prescription starting price, not an all-inclusive program quote; clinician visits, testing and other charges require a practice quote. The $149 starting price is for environmental drops.
Treatment commitment: Cost page describes treatment typically lasting 3–5 years; confirm the food-specific course with the prescriber.
Patient eligibility: Food page discusses mild/moderate and severe food allergies, with goals differing by severity. No food-specific minimum age is stated there; the treating clinician determines candidacy.
Outcomes and evidence boundaries: No network-wide food success rate is established by the checked pages. La Crosse clinic research cannot be assigned to every participating practice, every food or every compounded prescription.
Best fit: Patients who want custom food drops through their own clinician or a participating local practice.
What this option offers: A route to local clinician continuity and a transparent food-prescription starting price without requiring travel to the La Crosse clinic itself.

Sources checked October 5, 2026: Allergychoices food allergy treatment · Allergychoices food and environmental prescription costs · Allergychoices provider finder and limitations

United Allergy Services (UAS)

Partner-clinic food SLIT

Food treatment method: Food SLIT for IgE-mediated food allergy, separate from its environmental drops and environmental allergy shots. Its food FAQ describes daily home dosing, not food SCIT.
Delivery and location: Through participating allergy centers: each new three-month bottle starts with an in-office dose and 30-minute observation, then daily doses at home. Food challenges are referred to an allergist in a controlled setting, not performed at home or at the allergy center.
Pricing and publication status: No universal consumer food price published. The partner clinic sets the out-of-pocket bottle price; testing, bloodwork and visits are billed as usual. Program quote required from the treating center.
Treatment commitment: FAQ describes 3–5 years, sometimes longer; quarterly pickup/first-dose visits and annual blood testing.
Patient eligibility: Generally from about age 2 with confirmed immediate IgE-mediated food allergy; younger patients considered case by case. Controlled asthma and available epinephrine are required; active EoE and non-IgE conditions are not routine candidates.
Outcomes and evidence boundaries: The food FAQ describes treatment goals and protocol safety claims, not a published UAS food efficacy rate. UAS environmental at-home shot studies do not establish food-SLIT outcomes.
Best fit: Patients with access to a participating center who want food drops at home between recurring supervised pickup visits.
What this option offers: Local clinic involvement and an observed first dose for every bottle, plus explicit epinephrine checks and referral for supervised food challenges.

Sources checked October 5, 2026: UAS original food drops FAQ

How to read outcomes

These are different endpoints, not a league table. TIP success among completers, Latitude reaching maintenance, and tolerance at a research food challenge do not measure the same thing. Ask how many started, how many stopped, the challenge dose, the follow-up period, and whether benefit persists after stopping.

Provider marketing is labeled as such above. Neither a provider network nor a pharmacy inherits a clinic’s results simply because it uses a similarly named protocol. Environmental-allergy studies do not establish food treatment efficacy.

What original food research shows — and does not show

In the 2015 Narisety peanut pilot trial, 21 children aged 7–13 were randomized to OIT or SLIT. After 12 months, the challenge threshold increase was greater with OIT (141-fold versus 22-fold), but adverse reactions and early withdrawals were more frequent with OIT. This was a small peanut trial, not a comparison of these five providers.

In the 2024 Kim trial, 50 peanut-allergic children aged 1–4 received 4 mg peanut SLIT or placebo for 36 months. The median cumulative tolerated dose was 4,443 mg versus 143 mg; 60% versus 0% passed the month-36 challenge, and 48% versus 0% demonstrated remission after three months off treatment. These results apply to that studied dose, population and protocol; they do not establish outcomes for Curex, UAS or all Allergychoices prescriptions.

Allergy Associates of La Crosse is a separate Wisconsin clinic, not a substitute name for Allergychoices. Its 2024 retrospective shrimp report identified 66 treated patients, but only 18 underwent challenge; 11 of those 18 tolerated at least 42 g shrimp. This uncontrolled, single-practice report does not demonstrate network-wide effectiveness or permanent tolerance.

Sources: Narisety et al. 2015 — original peanut OIT/SLIT pilot trial · Kim et al. 2024 — original placebo-controlled peanut SLIT trial · Theodoropoulou and Cullen 2024 — original La Crosse shrimp report

Location, safety and the full quote decide fit

Compare the actual visit schedule, daily dosing rules, emergency plan and full cost before enrolling. A home dose is not a home food challenge. Food avoidance and prescribed epinephrine remain necessary until the treating clinician changes the plan; never try a challenge on your own.

Uncontrolled asthma, swallowing problems or possible eosinophilic esophagitis, and a history of severe reactions require clinical assessment before choosing a program. A history of anaphylaxis does not automatically select one brand or make unsupervised treatment appropriate.

Regulatory and guideline context

Compounded food allergy drops are not FDA-approved finished products; their safety and efficacy have not been evaluated by FDA as individual compounded formulations. Do not confuse an allergen extract’s status with approval of a food-SLIT prescription, or describe food SLIT as food allergy shots.

The AAO-HNSF 2024 Clinical Practice Guideline: Immunotherapy for Inhalant Allergy (DOI 10.1002/ohn.648) concerns inhalant allergic rhinitis, with or without allergic asthma. KAS 4 recommends explaining SCIT versus aqueous/tablet SLIT, including risks, benefits, convenience and cost, in that inhalant context; its comparison identifies aqueous SLIT as not FDA-approved (off-label) in the United States. It is not a food-allergy efficacy guideline and does not support food SCIT or a universal food standard-of-care claim.

Sources: AAO-HNSF 2024 guideline — inhalant context only

❓Frequently Asked Questions

Curex, Food Allergy Institute, Latitude Food Allergy Care, Allergychoices and United Allergy Services (UAS). Allergy Associates of La Crosse is discussed only as a separate clinic whose original research has limits; it is not a substitute for the Allergychoices pharmacy and participating-provider network.

Food Allergy Institute offers a structured, in-person multi-food TIP pathway and onsite challenges. Latitude offers supervised OIT updosing, food challenges and assessment of Xolair, with insurance billing for qualifying visits. Allergychoices enables treatment through participating local prescribers and publishes a food-prescription starting price. UAS combines daily home drops with quarterly observed first doses at a partner clinic. Confirm availability and candidacy with the actual treating practice.

Competitor prices checked October 5, 2026: FAI publishes $979/month for ages 18 months–25 and $1,079/month for ages 26–50, with exclusions to confirm. Allergychoices food prescriptions begin at $173/90 days, excluding a full treating-practice quote. Latitude publishes a non-covered one-time OIT program fee but no dollar amount in the checked FAQ; UAS says the partner clinic sets the food bottle price. Curex pricing was checked separately on 2026-10-09: Curex food-plan rates, checked 2026-10-09: Curex Food Insurance Plan: $199/month or $1,990/year, plus specialist copay; Curex Combo Insurance Plan: $259/month or $2,590/year, plus specialist copay; Curex Food Self Pay Plan: $249/month or $2,490/year; Curex Combo Self Pay Plan: $299/month or $2,990/year. Annual figures are plan prices, not all-in totals. Treatment fees are out of pocket; testing and consultations are insurance-dependent. See /learn/curex-pricing and confirm eligibility, additional charges and a personalized written quote Request a written all-in quote from your chosen program.

No. Allergychoices is a compounding pharmacy and provider-support network. Allergy Associates of La Crosse is a separate Wisconsin clinical practice. Sharing a La Crosse Method protocol does not mean every participating prescriber offers the same food program, accepts the same patients, or has the same outcomes.

Its original food page describes food SLIT, not food SCIT. UAS environmental shot studies are not food efficacy evidence. The food protocol includes an in-office first dose and 30-minute observation with each quarterly bottle, with later daily doses at home and food challenges referred to an allergist.

Not directly. FAI quotes success after completing TIP; Latitude’s checked FAQ reports reaching OIT maintenance; research trials measure tolerance to specific food challenge doses and sometimes remission after stopping. Ask about starters, withdrawals, endpoints and follow-up. Peanut-SLIT trials and a single-clinic shrimp report do not establish a brand-wide or network-wide rate.

No. It is Immunotherapy for Inhalant Allergy, focused on inhalant allergic rhinitis with or without allergic asthma. KAS 4 compares SCIT with aqueous/tablet SLIT for patient education in that context. It is not food-efficacy evidence and does not recommend food SCIT.

If you experience sudden difficulty breathing, throat swelling, or other signs of anaphylaxis, call 911. A prescribed epinephrine auto-injector is the first-line treatment — not antihistamines.

This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.

Sources